The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 26, 2016

Filed:

Dec. 21, 2011
Applicants:

Ramesh Kaul, Burnaby, CA;

Ernest J. Mceachern, Burnaby, CA;

Harold G. Selnick, West Point, PA (US);

David J. Vocadlo, Burnaby, CA;

Yuanxi Zhou, Burnaby, CA;

Yongbao Zhu, Burnaby, CA;

Inventors:

Ramesh Kaul, Burnaby, CA;

Ernest J. McEachern, Burnaby, CA;

Harold G. Selnick, West Point, PA (US);

David J. Vocadlo, Burnaby, CA;

Yuanxi Zhou, Burnaby, CA;

Yongbao Zhu, Burnaby, CA;

Assignees:

Alectos Therapeutics Inc., Burnaby, CA;

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C08B 37/00 (2006.01); C07D 487/02 (2006.01); A61K 31/70 (2006.01); A61K 31/425 (2006.01); C07H 17/00 (2006.01); C07D 513/04 (2006.01); C07H 9/06 (2006.01); C12Q 1/34 (2006.01);
U.S. Cl.
CPC ...
C07H 17/00 (2013.01); C07D 513/04 (2013.01); C07H 9/06 (2013.01); C12Q 1/34 (2013.01);
Abstract

The invention provides compounds with enhanced permeability for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc.


Find Patent Forward Citations

Loading…